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Haemothorax is a problem commonly encountered in medical practice and is most frequently
related to open or closed chest trauma or to invasive procedures of the chest. Spontaneous
haemothorax is less common and can have various causes, such as the use of anticoagulants,
neoplasia, and rupture of pleural adhesions. Identification by radiography and thoracentesis is
indicated and treatment of the underlying trauma should start immediately. After insertion of
a large chest tube, antibiotic prophylaxis in trauma patients should be administered for 24 h.
Further treatment depends on the haemodynamic stability of the patient, the volume of
evacuated blood and the occurrence of persistent blood loss. Surgical exploration by VATS
or thoracotomy is necessary if >1.500 ml of blood has accumulated and/or an ongoing produc-
tion of >200 ml of blood per hour is observed. If the haemorrhage is less severe, careful inves-
tigation into the underlying cause must be performed and blood should be evacuated by tube
thoracostomy. If clotted blood retained in spite of tube thoracostomy, intrapleural fibrinolytic
therapy can be applied to breakdown clots and adhesions. If conservative treatment is insuf-
ficient, a surgical approach with VATS or thoracotomy is indicated to prevent subsequent
complications.
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The exact incidence of haemothorax is not known. Chest
injuries occur in approximately 60% of all polytrauma cases
and haemothorax is most frequently caused by chest
trauma. A rough estimate of the occurrence of haemo-
thorax related to trauma in the United States approaches
300,000 cases per year.1 Generally, haemothorax can be
divided into two categories, based on aetiology: sponta-
neous and traumatic haemothorax.
This document represents the present knowledge about
treatment of haemothorax looking at the published litera-
ture. We performed a systemic search of the literature,
using the term “haemothorax” in PubMed. Articles pub-
lished between 1975 and September 2009 were included.
Definition
Haemothorax refers to a collection of blood within the
pleural cavity. By definition this bloody pleural effusion
should contain a haematocrit value of at least 50% of the
haematocrit of peripheral blood.
Aetiology
The primary cause of haemothorax is sharp or blunt trauma
to the chest. Iatrogenous and spontaneous haemothoraces
occur less frequently.
Iatrogenous haemothoraces are known to occur as
a complication of cardiopulmonary surgery, placement of
subclavian- or jugular-catheters or lung- and pleural-biop-
sies. Reported causes in the literature are, for example,
sclerotherapy of oesophageal varices, rupture of pulmonary
arteries after placement of SchwanneGanz catheters,
thoracic sympathectomy and translumbar aortography.2
Spontaneous haemothoraces are generally caused by
rupture of pleural adhesions (3e7% of all cases), neoplasma
(schwanommas, soft tissue tumours, and hepatocellular
carcinoma), pleural metastasis, and as a complication of
anticoagulant therapy for pulmonary embolism.3 Less
frequent causes reported in the literature are rupture
of aneurysmatic thoracic arteries such as the aorta,mammarian arteries and intercostal arteries (e.g. Ehlers
Danlos syndrome, and neurofibromatosis), rupture of
pulmonary vascular malformations (Rendu-Osler-Weber
syndrome), endometriosis, and exostoses.2,3
Pathogenesis
Bleeding into the pleural space can occur with virtually any
disruption of the tissues of the chest wall and pleura or the
intrathoracic structures. Blood that enters the pleural
cavity is exposed to the motion of the diaphragm, lungs,
and other intrathoracic structures. This results in some
degree of defibrination of the blood so that incomplete
clotting occurs. Within several hours of cessation of
bleeding, lysis of existing clots by pleural enzymes begins.
However, when this lysis is incomplete or bleeding is rela-
tively large, clot formation is inevitably.
Once the clot has been allowed to organize, it will
adhere to the lung and pleura, making it difficult to
remove. The agitation of cardiac and respiratory movement
rapidly defibrinates the blood, and a fibrin clot thus formed
is deposited on the visceral and parietal pleura, setting the
stage for a trapped lung. In its early development, this thin
membrane has little substance and is attached very loosely
to the underlying pleural surface. By the seventh day, there
is an angioblastic and fibroblastic proliferation. The
membrane continues to thicken by progressive deposition
and organization of the coagulum within the cavity. An
understanding of the pathologic features of a clotted hae-
mothorax makes it clear that, if possible, the clotted hae-
mothorax should be evacuated within a reasonable time
after onset of bleeding.
Initial treatment
Chest tube drainage
In most cases, chest tube drainage by means of a large
calibre (28 French) tube is an adequate initial approach
unless an aortic dissection or rupture is suspected.2,3 After
the tube thoracostomy is performed, a chest radiograph
should always be repeated in order to identify the position
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and to confirm whether the collection of blood within the
pleural cavity has been fully drained.
Surgical approach in the acute phase
The criteria for surgical exploration, as detailed in the
literature, are blood loss by chest tube 1.500 ml in 24 h or
200 ml per hour during several successive hours and the
need for repeated blood transfusions to maintain haemo-
dynamic stability.4e6
Patients with active blood loss but with stable haemo-
dynamics can be treated with Video-Assisted Thoracoscopic
Surgery (VATS), not only to stop the bleeding but also to
evacuate blood clots and breakdown adhesions. A series of
50 VATS procedures, performed in patients with traumatic
haemothorax, demonstrated active blood loss in eleven
subjects.4
Thoracotomy is the procedure of choice for patients
with haemodynamic instability due to active bleeding.2
Surgical exploration allows control of the source of
bleeding and evacuation of the intrathoracic blood.
Prophylactic antibiotics
Antibiotic treatment following haemothorax reduces the
rate of infectious complications.7e10 The Eastern Associa-
tion for Trauma developed guidelines based on nine
prospective placebo-controlled studies, including several
double blinded studies and two meta analyses. Most of the
cases enrolled in these studies were penetrating chest
traumas, but some studies also included patients with
spontaneous haemothorax. The guidelines recommend the
use of first generation cephalosporins during the first 24 h in
patients treated with chest tube drainage for haemothorax.
In the included studies however, a broad range of antibi-
otics was applied. When empyema occurs during chest tube
drainage, antibiotic treatment should be directed to
Staphylococcus aureus and Streptococcus species.8
In a comment on this guideline, results of different
studies were combined to generate incidence rates. The
authors concluded that prophylactic use of antibiotics
during at least 24 h after the start of chest tube drainage
for haemothorax, reduced the incidence of pneumonia
from 14.8% to 4.1%.9 The incidence of empyema decreased
from 8.7% to 0.8%.
Another randomised controlled study, performed after
the publication of these guidelines, also revealed fewer
infectious complications in the group of patients treated
with prophylactic antibiotics.10
The duration of antibiotic treatment remains a point of
discussion and recommendations vary from 24 h to the
moment of chest tube removal. In general, 24 h of antibi-
otic treatment is advised in traumatic haemothorax.8
Whether antibiotic prophylaxis is useful for spontaneous
haemothorax has not been investigated accurately.
Intrapleural fibrinolytic therapy
Intrapleural fibrinolytic therapy (IPFT) can be applied in an
attempt to evacuate residual blood clots and breakdownadhesions when initial tube thoracostomy drainage is
inadequate. Retention of blood in the pleural cavity may
lead to lung entrapment, chronic fibrothorax, impaired lung
function and infection. Several small non-randomised
studies report on IPFT with streptokinase (250,000 IU),
urokinase (100,000 IU or 250,000 IU) or tissue plasminogen
activator (TPA).11e16 The intervals between the day of
onset of haemothorax and the start of treatment varied
from 4 to 165 days. Whether IPFT can be initiated prior to
the fourth day is not clear from the published reports.
Generally, it is advised to evacuate the clotted haemo-
thorax within 7e10 days.4
Reports on duration of treatment with IPFT vary
between 2 and 9 days for streptokinase and 2e15 days for
urokinase.
In most cases, treatment with IPFT leads to complete
resolution of radiographic abnormalities, through evacua-
tion of blood clots and loculated effusions. Less than 10% of
cases need a more aggressive treatment by means of
surgical decortication.
Bleeding complications due to a possible systemic effect
of fibrinolytic substances were not reported in the studies
using streptokinase and urokinase. A study using recombi-
nant tissue plasminogen activator as a fibrinolytic agent,
was reported on one patient who developed haematuria
requiring blood transfusion.16
The relationship between the time frame of IPFT or
conversion to surgical intervention and the risk of devel-
oping long-term complications has not been established in
the published literature.
If chest tube drainage and IPFT does not lead to suffi-
cient resolution of the retained clots, surgical intervention
should be considered.
Surgical approach in a later phase
VATS
Optimal evacuation of residual clots, breakdown of adhe-
sions and loculated effusions is important in order to
prevent a complicated course leading to empyema or
fibrothorax. A volume of 500 ml of blood or an amount of
blood filling one third of a hemithorax is considered an
indication for surgery.17e20
Chest X-ray seems to be an inadequate tool in estab-
lishing the indication for VATS. The surgical procedure
should therefore be preceded by computer tomography
(CT), to be able to detect locations and residual clots with
high accuracy.18,21,22
The estimated amount of fluid on CT scans has been
shown to correlate very well with the true amount of fluid
harvested by VATS.22
VATS evacuation of the haemothorax or retained clot
can be performed safely. One-lung ventilation is not
required. A single lumen tube can be used with directions
to anaesthesiologist to decrease tidal volume or intermit-
tently hold ventilation during the procedure. If cardiac,
great vessel, or tracheobronchial injury is found, conver-
sion to thoracotomy can be performed expeditiously.
A randomised study in patients with incomplete resolu-

































Figure 1 Algorithm of therapeutic approach of traumatic haemothorax and spontaneous haemothorax.
1586 W.G. Boersma et al.shorter length of hospital stay and shorter duration of
tube drainage in a group of patients treated with VATS
as compared to a group treated with additional tube
drainage.17
Several prospective and retrospective non-randomised
studies in small groups of patients show favourable results
of VATS (80%e100%) with high effectiveness and low
morbidity.6,19e21,21e26
However, the methods of evaluation were not reported
in all of these studies and IPFT was not integrated in the
therapeutic strategy. An optimal period between trauma
and VATS of 48e72 h is repeatedly advocated, although
a longer interval is more common.6,19,21,26
Longer intervals between the start of haemothorax and
VATS lead to increased rates of complications, according to
some authors.19,20
Thoracotomy
Thoracotomy is the procedure of choice for surgical
exploration of the chest when massive haemothorax or
persistent bleeding is present. At the time of surgical
exploration, the source of bleeding can be controlled and
a haemothorax evacuated. Thoracotomy is usually required
for adequate empyema drainage and/or decortication. In
10% of cases a thoracotomy is necessary to treat the
haemothorax.6
A longer time span between the appearance of haemo-
thorax and VATS increases the chance of intraoperative
conversion to thoracotomy, prolongs postoperative
drainage time and is associated with a higher incidence of
hospital admissions.19,27 When haemothorax is complicated
by empyema, the duration of hospital stay also increases.19Algorithm
Based on the information derived from the literature, an
algorithm was designed to be used in the approach of
patients with haemothorax (Fig. 1). At first, laceration of
blood vessels and other leaking vessels (e.g. aortic aneu-
rysm, lobar sequestration, and arteriovenous malforma-
tion) should be excluded radiographically.
Secondly, blood should be evacuated immediately
following tube thoracostomy. In haemodynamically
unstable patients inspection and drainage of the pleural
cavity by thoracotomy is indicated, whereas in haemody-
namically stable patients VATS is considered the treatment
of choice. In residual haemothorax, IPFT, with daily appli-
cation of streptokinase, urokinase or TPA, is indicated for
local fibrinolysis. If treatment with IPFT is not successful,
surgery is the treatment of choice to prevent development
of pleural thickening and fibrosis.
In patients with traumatic haemothorax antibiotic
prophylaxis 24 h is indicated.
Because the literature does not provide data for an
optimal time frame between IFPT and VATS, we chose to
abstain from providing one in the algorithm. It appears
logical to commence chest tube drainage followed by IPFT
before proceeding to VATS if there is residual blood in the
thorax.
Although fibrinolytic treatment was initiated at least 4
days after the onset of haemothorax in most trials, it is
probably safe to start earlier in the course of treatment.
Intrapleural deposition of fibrinolytics is not very likely to
cause systemic effects.28 IPFT is not indicated when coa-
gulopathy or vascular lesions (e.g. angiosarcomas, pulmonary
vascular malformations, and aneurysms) may be present.
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Haemothorax is a relatively common problem, most often
resulting from injury to intrathoracic structures of the
chest wall. Non-traumatic haemothorax can be a compli-
cation due to various causes. Rapid identification of the
cause and initiation of treatment is essential. In haemo-
dynamically unstable patients tube drainage and surgery is
indicated. In haemodynamically stable patients evacuation
of blood from the pleural cavity by chest tube with or
without IPFT should be performed. If this treatment is not
successful, surgery is indicated in order to prevent long-
term complications and impaired pulmonary function.
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